Abstract
Background
This study was conducted to compare concentrations of VEGF family growth factors, inflammation-related factors, and adhesion molecules in the aqueous humor of eyes with diabetic macular edema (DME), with and without prior vitrectomy.
Methods
A total of 31 eyes were included, 11 with DME that had undergone vitrectomy, 9 with DME but without vitrectomy, and 11 from age-related cataract patients as controls. The concentrations of cytokines including TNF-α, IL-6, IL-8, IP-10, MCP-1, IFN-γ, MIP-1 α, MIP-1 β, PECAM-1, MIF, VCAM-1, ICAM-1, PIGF were quantified using Luminex Human Discovery Assay. Central macular thickness (CMT) values of all eyes were measured using optical coherence tomography (OCT).
Results
(1) Vitrectomized DME eyes exhibited significantly higher levels of IL-6 and IL-8 compared to non-vitrectomized eyes (P < 0.05). (2) In vitrectomized group, after Benjamini–Hochberg correction, there was a significant positive correlation between the levels of VEGF and PlGF (rs = 0.855, P < 0.05), as well as the levels of TNF-α and IFN-γ (rs = 0.858, P < 0.05). In non-vitrectomized group, significant positive correlations were found between VEGF and PlGF levels after correcting for multiple comparisons (rs = 0.9, P < 0.05). (3) In non-vitrectomized group, the concentrations of VEGF and PlGF in aqueous humor were significantly positively correlated with CMT values (rs = 0.95, P < 0.05; rs = 0.9, P < 0.05, respectively).
Conclusions
The concentrations of IL-6 and IL-8 in the aqueous humor were significantly higher in vitrectomized DME eyes compared to nonvitrectomized DME eyes and the levels of VEGF were similar in the two groups, suggesting that inflammation after vitrectomy may be a key factor in the occurrence and development of DME.
Similar content being viewed by others
Data availability
The data used to support the findings of this study are available from the corresponding author upon request.
Abbreviations
- TNF-α:
-
Tumor necrosis factor alpha
- IL-6:
-
Interleukin-6
- IL-8:
-
Interleukin-8
- IP-10:
-
Interferon-inducible protein 10
- MCP-1:
-
Monocyte chemotactic protein 1
- IFN-γ:
-
Interferon gamma
- MIP-1 α:
-
Macrophage inflammatory protein-1 alpha
- MIP-1 β:
-
Macrophage inflammatory protein-1 beta
- PECAM-1:
-
Platelet endothelial cell adhesion molecule-1
- MIF:
-
Macrophage migration inhibitory factor
- VCAM-1:
-
Vascular cell adhesion molecule-1
- ICAM-1:
-
Intercellular adhesion molecule-1
- PIGF:
-
Placental growth factor
- VEGF:
-
Vascular endothelial growth factor
- CMT:
-
Central macular thickness
- DME:
-
Diabetic macular edema
- DR:
-
Diabetic retinopathy
- BRB:
-
Blood-retinal barrier
- OCT:
-
Optical coherence tomography
References
Glassman AR, Wells JA 3rd, Josic K, Maguire MG, Antoszyk AN, Baker C, Beaulieu WT, Elman MJ, Jampol LM, Sun JK (2020) Five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (Protocol T Extension Study). Ophthalmology 127:1201–1210
Liu K, Wang H, He W, Ye J, Song Y, Wang Y, Liu X, Wu Z, Chen S, Fan K et al (2022) Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study. Br J Ophthalmol 106:1436–1443
Yoshida S, Kubo Y, Kobayashi Y, Zhou Y, Nakama T, Yamaguchi M, Tachibana T, Ishikawa K, Arita R, Nakao S et al (2015) Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: Possible association with postoperative macular oedema. Br J Ophthalmol 99:960–966
Yanyali A, Aytug B, Horozoglu F, Nohutcu AF (2007) Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Am J Ophthalmol 144:124–126
Koyanagi Y, Yoshida S, Kobayashi Y, Kubo Y, Yamaguchi M, Nakama T, Nakao S, Ikeda Y, Ohshima Y, Ishibashi T et al (2016) Comparison of the effectiveness of intravitreal ranibizumab for diabetic macular edema in vitrectomized and nonvitrectomized eyes. Ophthalmologica 236:67–73
Chen YY, Chen PY, Chen FT, Chen YJ, Wang JK (2018) Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema. Int Ophthalmol 38:293–299
Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, Hori S (2005) Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefe’s Arch Clin Exp Ophthalmol 243:3–8
Lee SS, Ghosn C, Yu Z, Zacharias LC, Kao H, Lanni C, Abdelfattah N, Kuppermann B, Csaky KG, D’Argenio DZ et al (2010) Vitreous VEGF clearance is increased after vitrectomy. Investig Ophthalmol Vis Sci 51:2135–2138
Niwa Y, Kakinoki M, Sawada T, Wang X, Ohji M (2015) Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous VEGF level in vitrectomized and nonvitrectomized macaque eyes. Investig Ophthalmol Vis Sci 56:6501–6505
Kakinoki M, Sawada O, Sawada T, Saishin Y, Kawamura H, Ohji M (2012) Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys. Investig Ophthalmol Vis Sci 53:5877–5880
Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039
Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP (2000) Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156:1733–1739
De Falco S, Gigante B, Persico MG (2002) Structure and function of placental growth factor. Trends Cardiovasc Med 12:241–246
DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor·placenta growth factor heterodimer. J Biol Chem 270:7717–7723
Noma H, Mimura T, Yasuda K, Motohashi R, Kotake O, Shimura M (2017) Aqueous humor levels of soluble vascular endothelial growth factor receptor and inflammatory factors in diabetic macular edema. Ophthalmologica 238:81–88
Bressler SB, Melia M, Glassman AR, Almukhtar T, Jampol LM, Shami M, Berger BB, Bressler NM (2015) Ranibizumab plus prompt or deferred laser for diabetic macular edema in eyes with vitrectomy before anti-vascular endothelial growth factor therapy. Retina 35(12):2516–2528
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn E (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549–580
Ferrara N, Gerber HP, LeCouter J (1995) The biology of VEGF and its receptors. Nat Med 9:669–676
Wang H, Lafdil F, Kong X, Gao B (2011) Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci 7:536–550
Ebihara N, Matsuda A, Nakamura S, Matsuda H, Murakami A (2011) Role of the IL-6 classic-and trans-signaling pathways in corneal sterile inflammation and wound healing. Investig Ophthalmol Vis Sci 52:8549–8557
Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S (2003) Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110:1690–1696
Roh MI, Kim HS, Song JH, Lim JB, Kwon OW (2009) Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology 116:80–86
Jo N, Wu GS, Rao NA (2003) Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Investig Ophthalmol Vis Sci 44:4054–4060
Funk M, Schmidinger G, Maar N, Bolz M, Benesch T, Zlabinger GJ, Schmidt-Erfurth UM (2010) Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 30:1412–1419
Ide N, Hirase T, Nishimoto-Hazuku A, Ikeda Y, Node K (2008) Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells. Hypertens Res 31:1257–1267
Yoshimura T (2018) The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol 15:335–345
Hong KH, Ryu J, Han KH (2005) Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105:1405–1407
Gu R, Zhou M, Jiang C, Yu J, Xu G (2016) Elevated concentration of cytokines in aqueous in post-vitrectomy eyes. Clin Exp Ophthalmol 44:128–134
Park YG, Jee D, Kwon J (2019) Aqueous humor cytokine levels in diabetic macular edema patients with cotton-wool spots. J Diabetes Res 2019:1–9
Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30:343–358
Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP (2002) Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 160:501–509
Hillier RJ, Ojaimi E, Wong DT, Mak MY, Berger AR, Kohly RP, Kertes PJ, Forooghian F, Boyd SR, Eng K et al (2017) Aqueous humor cytokine levels as biomarkers of disease severity in diabetic macular edema. Retina 37:761–769
Oh IK, Kim SW, Oh J, Lee TS, Huh K (2010) Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res 35:1116–1127
Funding
This research was funded by the National Natural Science Foundation of China (No. 82000917). Yuzhi Ding has been supported by the “Best Young Scholars” Fellowship from Southeast University.
Author information
Authors and Affiliations
Contributions
Examined and analyzed the aqueous humor data, and was a major contributor in writing the manuscript: YHW, YZD. Optimization of the manuscript: QYZ. Design of the study and final review of the manuscript: JL. All authors (YHW, YZD, QYZ, JL) read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interest
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical approval and consent to participate
This study was approved by the Clinical research ethics committee of Zhongda Hospital, Affiliated with Southeast University, Nanjing, Jiangsu Province, China (approval number: 2022ZDSYLL112-P01). All methods were carried out in accordance with relevant guidelines and regulations. All patients provided a written informed consent before enrollment.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Y., Ding, Y., Zhuang, Q. et al. Comparison of the cytokines levels in aqueous humor in vitrectomized eyes versus non-vitrectomized eyes with diabetic macular edema. Int Ophthalmol 44, 220 (2024). https://doi.org/10.1007/s10792-024-03136-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10792-024-03136-3